After adjusting for the level of underlying disease, women appear to gain more benefit from cardiac resynchronization therapy (CRT) than men, a sub-analysis of a randomized trial affirmed.
Women had significantly better one-year survival and freedom from cardiovascular hospitalization, as well as larger gains in quality of life, Ulrika Birgersdotter-Green, MD, of the University of California San Diego, reported here at EHRA EUROPACE, the meeting of the European Heart Rhythm Association.
For more: Medical News: EUROPACE: CRT of More Benefit to Women than Men - in Meeting Coverage, EUROPACE from MedPage Today
No comments:
Post a Comment